These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 19664395)
1. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2]. Han PH; Li XJ; Qin H; Yao J; DU N; Ren H Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395 [TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer]. Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995 [TBL] [Abstract][Full Text] [Related]
3. Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer. Gao Q; Yang S; Kang MQ Mol Med Rep; 2012 Jun; 5(6):1409-14. PubMed ID: 22446832 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases. Kren L; Brazdil J; Hermanova M; Goncharuk VN; Kallakury BV; Kaur P; Ross JS Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):44-9. PubMed ID: 15163019 [TBL] [Abstract][Full Text] [Related]
5. [Expression of survivin and its clinical significance in non-small cell lung cancer]. Ren YJ; Zhang QY Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):504-7. PubMed ID: 16224523 [TBL] [Abstract][Full Text] [Related]
6. Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer. Porebska I; Sobańska E; Kosacka M; Jankowska R Cancer Genomics Proteomics; 2010; 7(6):331-5. PubMed ID: 21156966 [TBL] [Abstract][Full Text] [Related]
8. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer. Liu J; Lin Y; Yang H; Deng Q; Chen G; He J Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982 [TBL] [Abstract][Full Text] [Related]
9. [Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer]. Zhou JM; Zhou JH; Deng ZH; Zheng H; Jiang HY; Cao HQ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):544-8. PubMed ID: 16320585 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer. Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135 [TBL] [Abstract][Full Text] [Related]
11. [Microvessel density and expressions of survivin and vascular endothelial growth factor in non-small cell lung cancer and their correlations to clinicopathologic features]. Wang L; Li X; Li Y; Xue YW Ai Zheng; 2005 Jul; 24(7):823-6. PubMed ID: 16004808 [TBL] [Abstract][Full Text] [Related]
12. Expression of survivin, caspase-3 and p53 in cervical cancer assessed by tissue microarray: correlation with clinicopathology and prognosis. Lu H; Gan M; Zhang G; Zhou T; Yan M; Wang S Eur J Gynaecol Oncol; 2010; 31(6):662-6. PubMed ID: 21319512 [TBL] [Abstract][Full Text] [Related]
13. [Expression of survivin and its correlation with p53 and bcl-2 expression in laryngeal and hypopharyngeal cancer]. Sun M; Qin Y Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Apr; 22(8):346-8, 351. PubMed ID: 18595518 [TBL] [Abstract][Full Text] [Related]
14. Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers. Harada T; Ogura S; Yamazaki K; Kinoshita I; Itoh T; Isobe H; Yamashiro K; Dosaka-Akita H; Nishimura M Cancer Sci; 2003 Apr; 94(4):394-9. PubMed ID: 12824911 [TBL] [Abstract][Full Text] [Related]
15. Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer. Lai RS; Wang JS; Hsu HK; Chang HC; Lin CH; Lin MH Jpn J Clin Oncol; 2002 Oct; 32(10):393-7. PubMed ID: 12451034 [TBL] [Abstract][Full Text] [Related]
16. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition. Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977 [TBL] [Abstract][Full Text] [Related]
18. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865 [TBL] [Abstract][Full Text] [Related]
19. Survivin expression in non-small-cell lung carcinomas: correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis. Ulukus EC; Kargi HA; Sis B; Lebe B; Oztop I; Akkoclu A; Onen A; Sanli A Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):31-7. PubMed ID: 17536304 [TBL] [Abstract][Full Text] [Related]
20. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014). Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]